Hepatitis SurveillanceReferences
Issued April, 1996 1. McQuillan GM, Townsend TR, Fields HA, et al. Seroepidemiology of hepatitis B virus infection in the United States. Am J Med 1989;87(suppl 3A):5S-10S. 2. Francis DP, Maynard JE. The transmission and outcome of hepatitis A, B, and nonA, nonB: a review. Epidemiol Rev 1979;1:1731. 3. Corey L, Holmes KK. Sexual transmission of hepatitis A in homosexual menincidence and mechanism. N Engl J Med 1980;302:4358. 5. Hadler SC, Doto IL, Maynard JE, et al. Occupational risk of hepatitis B infection in hospital workers. J Infect Control 1985;6:2431. 6. Schreeder MT, Thompson SE, Hadler SC, et al. Hepatitis B in homosexual men: prevalence of infection and factors related to transmission. J Infect Dis l982;146:715. 7. Alter MJ, Hadler SC, Margolis HS, et al. The changing epidemiology of hepatitis B in the United States. JAMA 1990;263:1218-22. 8. Immunization Practices Advisory Committee. Recommendations for protection against viral hepatitis. MMWR 1985;34:31324,32935. 9. Immunization Practices Advisory Committee. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. MMWR 1991;40:1-25. 10. Immunization Practices Advisory Committee. Update: recommendations to prevent hepatitis B virus transmission -- United States. MMWR 1995;44:574-5. 11. Margolis HS, Alter MJ, Hadler SC. Hepatitis B: evolving epidemiology and implications for control. Semin Liver Dis 1991;11:84-92. 12. Alter MJ, Coleman PJ, Alexander WJ, et al. Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis. JAMA 1989;262:1201-5. 13. Alter MJ, Hadler SC, Judson FN, et al. Risk factors for acute nonA, nonB hepatitis in the United States and association with hepatitis C virus infection. JAMA 1990;264:2231-5. 14. Alter MJ. The detection, transmission, and outcome of hepatitis C virus infection. Infectious Agents and Disease 1993;2:155-66. 15. Aach RD, Szmuness W, Mosley JW, et al. Serum alanine aminotransferase of donors in relation to the risk of nonA, nonB hepatitis in recipients. N Engl J Med 1981;304:98994. 16. Koziol DE, Holland PV, Alling DW, et al. Antibody to hepatitis B core antigen as a paradoxical marker for nonA, nonB hepatitis agents in donated blood. Ann Intern Med 1986;104:48895. 17. CDC. Enterically transmitted nonA, nonB hepatitis Mexico. MMWR 1987;36:597602. 18. Bellabbes EH, Bourguermouh A, Benatallah A, Illoul G. Epidemic non-A, non-B hepatitis in Algeria: strong evidence for its spreading by water. J Med Virol 1985;16:257-63. 19. Mast EJ, Alter MJ. Epidemiology of viral hepatitis: an overview. Seminars in Virology 1993;4:273-83. 20. DeCock KM, Bradley DW, Sandford NG, Govindarajan S, Maynard JE, Redeker AG. Epidemic non-A, non-B hepatitis in patients from Pakistan. Ann Intern Med 1987;106:227-30. 21. Alter MJ, Mares A, Hadler SC, Maynard JE. The effect of underreporting on the apparent incidence and epidemiology of acute viral hepatitis. Am J Epidemiol 1987;125:1339.
This article was provided by U.S. Centers for Disease Control and Prevention. |
|